Chemical formula: C₁₉H₂₇NO Molecular mass: 285.431 g/mol PubChem compound: 441278
Pentazocine is an opioid, benzomorphan derivative analgesic with actions and uses similar to those of morphine. It has weak narcotic antagonist actions.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02AD01 | Pentazocine | N Nervous system → N02 Analgesics → N02A Opioids → N02AD Benzomorphan derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| PENTAZOCINE Capsules, hard | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Pentazocine is an active ingredient of these brands:
Canada (CA)
Japan (JP)
Nigeria (NG)
South Africa (ZA)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
